Aris Global Announces agCapture
AT THE 45th ANNUAL DIA CONFERENCE (SAN DIEGO, CA)-June 22, 2009: Aris Global, the leading provider of software solutions for the life sciences industry, today announced the introduction of agCapture, an integrated EDC solution that offers life science organizations a cost-effective alternative for capturing, managing and reporting clinical research data. Companies will now be able to conduct all data management activities electronically and seamlessly integrate with other systems and departments, such as safety and CTMS. The level of interoperability and integration that agCapture offers will appeal to organizations that want to eliminate duplicate data entry, and prevent delays and inefficiencies in adverse event reporting.
During the DIA 45th Annual Meeting, Aris Global will be demonstrating and presenting agCapture in its booth #521 at the San Diego Convention Center.
agCapture is an industry-proven EDC system, based on software developed by Aris Global and InferMed, a leading provider of advanced decision support and data-capture solutions for clinical research and practice. The solution seamlessly integrates with ARISg, the market-leading pharmacovigilance system from Aris Global, enabling companies to reduce the efforts required for SAE reconciliation and immediately take the necessary steps for case processing. agCapture provides interoperability with clinical systems such as central labs, ePRO, interactive voice response systems (IVRS), and clinical trial management systems, including Aris Global’s agClinical, to help easily manage complex trials from end to end. A number of intuitive, interactive tools for study definition, online and off-line remote data entry, and remote study monitoring simplify study setup and shorten the time to database closure. Service offerings include study setup, training, integration with third-party software, and 24x7x365 multi-language support for investigators.
“Aris Global effectively addresses the needs of life science organizations to keep their global trials on track, on budget, and on time,” said Simon Sparkes, vice president, corporate strategy and marketing, Aris Global. “With this offering, companies benefit from having a proven EDC solution that has been deployed worldwide in hundreds of sites and studies, is interoperable with third-party clinical and pharmacovigilance systems, and is backed by the stability, leadership and responsive support that Aris Global has been delivering for more than 20 years.”
Delivered as a hosted Software-as-a-Service offering, agCapture will also help reduce costs by eliminating the investment in new software, hardware, or new application and infrastructure support staff. The solution is offered at a pricing level that is specifically designed to accommodate a multitude of changes, making it affordable for companies looking to reduce costs and stay within set budgets.
About Aris Global
Aris Global is a leading provider of integrated software solutions for pharmacovigilance and safety, regulatory affairs, clinical research and medical information. More than 300 life science organizations rely on the company’s advanced solutions for maintaining regulatory compliance, managing and mitigating risk, improving operational efficiency and easily sharing information on a global basis.
Behind the Buzz: Why Clinical Research Leaders Flock to SCOPE Summit
February 7th 2025In this episode, we meet with Micah Lieberman, Executive Conference Director for SCOPE Summit (Summit for Clinical Ops Executives) at Cambridge Innovation Institute. We will dive deep into the critical role of collaboration within the clinical research ecosystem. How do we bring together diverse stakeholders—sponsors, CROs, clinical trial tech innovators, suppliers, patients, sites, advocacy organizations, investors, and non-profits—to share best practices in trial design, program planning, innovation, and clinical operations? We’ll explore why it’s vital for thought leaders to step beyond their own organizations and learn from others, exchanging ideas that drive advancements in clinical research. Additionally, we’ll discuss the pivotal role of scientific conferences like SCOPE Summit in fostering these essential connections and collaborations, helping shape the future of clinical trials. Join us as we uncover how collective wisdom and cross-industry partnerships are transforming the landscape of clinical research.
Reaching Diverse Patient Populations With Personalized Treatment Methods
January 20th 2025Daejin Abidoye, head of solid tumors, oncology development, AbbVie, discusses a number of topics around diversity in clinical research including industry’s greatest challenges in reaching diverse patient populations, personalized treatment methods, recruitment strategies, and more.
POETYK PsA-2 Trial Shows Efficacy of Sotyktu as an Oral Therapy for Psoriatic Arthritis
March 11th 2025Sotyktu (deucravacitinib) demonstrated significant efficacy in improving psoriatic arthritis symptoms compared to placebo in the Phase III POETYK PsA-2 trial, with a well-tolerated safety profile.
